Loading...
Surgical resection of lung adenocarcinoma after crizotinib treatment: report of a case
A 45-year-old female was diagnosed as having lung adenocarcinoma harboring an anaplastic lymphoma kinase (ALK) rearrangement, stage IV (T2bN3M1b). She was treated with crizotinib as second-line chemotherapy. The clinical stage after crizotinib treatment was ycT2aN0M0, stage IB. We performed a left l...
Na minha lista:
| Udgivet i: | World J Surg Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4342155/ https://ncbi.nlm.nih.gov/pubmed/25889062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-015-0480-2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|